Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism.
about
What We Have Learned about Autism Spectrum Disorder from Valproic AcidValproic acid induces monoamine oxidase A via Akt/forkhead box O1 activationClinical and Neurobiological Relevance of Current Animal Models of Autism Spectrum Disorders.The serotonin system in autism spectrum disorder: From biomarker to animal modelsPax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspringDoes Prenatal Valproate Interact with a Genetic Reduction in the Serotonin Transporter? A Rat Study on Anxiety and Cognition.Behavioral Phenotyping of Juvenile Long-Evans and Sprague-Dawley Rats: Implications for Preclinical Models of Autism Spectrum DisordersPre-clinical models of neurodevelopmental disorders: focus on the cerebellumImpact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.Gene-class analysis of expression patterns induced by psychoactive pharmaceutical exposure in fathead minnow (Pimephales promelas) indicates induction of neuronal systems.Acute prenatal exposure to a moderate dose of valproic acid increases social behavior and alters gene expression in rats.Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay.From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects.Psychoactive pharmaceuticals induce fish gene expression profiles associated with human idiopathic autismEnvironmental risk factors for autism.Suppression of NMDA receptor function in mice prenatally exposed to valproic acid improves social deficits and repetitive behaviors.Genetic and pharmacological manipulations of the serotonergic system in early life: neurodevelopmental underpinnings of autism-related behavior.Biological mechanisms associated with increased perseveration and hyperactivity in a genetic mouse model of neurodevelopmental disorderGeneral developmental health in the VPA-rat model of autismRetinoic acid influences neuronal migration from the ganglionic eminence to the cerebral cortexValproic acid silencing of ascl1b/Ascl1 results in the failure of serotonergic differentiation in a zebrafish model of fetal valproate syndromeLate onset deficits in synaptic plasticity in the valproic acid rat model of autismDivergent dysregulation of gene expression in murine models of fragile X syndrome and tuberous sclerosis.Perinatal Influences of Valproate on Brain and Behaviour: An Animal Model for Autism.Oxytocin and Animal Models for Autism Spectrum Disorder.The Role of the Oxytocin/Arginine Vasopressin System in Animal Models of Autism Spectrum Disorder.Developmental disruption of amygdala transcriptome and socioemotional behavior in rats exposed to valproic acid prenatally.Developmental profiling of ASD-related shank3 transcripts and their differential regulation by valproic acid in zebrafish.Epigenetic changes and disturbed neural development in a human embryonic stem cell-based model relating to the fetal valproate syndrome.Downregulating the canonical Wnt/β-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress.D-Cycloserine ameliorates social alterations that result from prenatal exposure to valproic acid.Serotonin neuron abnormalities in the BTBR mouse model of autism.Postnatal Stress Induced by Injection with Valproate Leads to Developing Emotional Disorders Along with Molecular and Cellular Changes in the Hippocampus and Amygdala.Altered attentional processing in male and female rats in a prenatal valproic acid exposure model of autism spectrum disorder.Overexpression of Telomerase Reverse Transcriptase Induces Autism-like Excitatory Phenotypes in Mice.Autism spectrum disorder traits in Slc9a9 knock-out mice.Deep Brain Stimulation Modified Autism-Like Deficits via the Serotonin System in a Valproic Acid-Induced Rat Model
P2860
Q21284783-BB1BE8B1-9F60-40D8-B336-A9B4C803054CQ24635235-215B7E74-7020-49BC-807F-E8D745F5A66CQ26748761-24CF7F07-168E-4546-A529-759DF199C065Q28391614-8234E2AA-9227-42D9-B27A-653B777A1602Q28941206-52B18659-0134-49E4-9622-A38190E41CBDQ30372826-79473C24-9216-4484-910F-D0A0B2E4A9A3Q30378813-5B687EE1-F975-4530-AF05-F656F0ECBC61Q30436913-271792F2-1B02-477F-A25F-77ECCFD0D930Q30443028-3B9CA0D6-C844-4BFF-86FF-28B666781A19Q30459493-DC03AE1A-991D-4521-ABA4-98FEF74055FFQ30560373-FF7D31B8-172D-4BA9-AA4B-B38A039D382AQ33551798-601690B4-E88C-427E-8A21-76FC604835E2Q33794480-B2C6E6DA-895E-46D2-B9B5-3DCBC55643CDQ34305076-445E6C7F-1D8D-4673-A7F8-59913BB13920Q35200038-63780D17-938C-46CB-B908-C526A13E2067Q35650220-6A045F04-CF86-4694-83F2-39AAC3E2A6B6Q36921232-52B790DF-D182-4788-8E46-9631030DEE37Q36949345-35EBF700-6DB5-40CB-844E-7916BA97C3FBQ37039400-C6B21C7F-1552-4A00-91D9-6FA861A7648AQ37066125-55B9CBE0-B264-4314-A08F-3F4D7EF7D742Q37438521-704CFE97-675D-4C99-87F0-349B3BE060A1Q37535064-8978BC1C-D6B0-486B-A56A-E9B277295193Q37613392-E1DFBC60-CEB7-45A7-B04A-540317027776Q38618627-DB4B76AB-AA41-4120-9F21-E4AC0C3CF85AQ38634066-A67F9D6B-373C-4B18-885E-8506C9F65F6EQ38678068-156CB97A-784E-4185-A822-27B786D75A1DQ41206601-6FB2F657-9901-4292-9D24-2203D68AAF52Q42372591-922B206F-300A-41D2-A67F-87BA8742A28CQ42717337-8ACA0AF6-20C5-456A-9D58-9DE09FA2B5D9Q45414556-9C1AA4B8-602E-4089-9963-DC5F4D195639Q47133904-59F154CD-FC8F-46FA-8CC5-A61193FC0E9BQ47137996-2B52C879-C532-4FDA-A99F-DA63ABFCC30AQ47609543-1B60F512-7909-4781-8C24-C4B8E8745463Q47634845-4DE4F00B-F49C-4467-998A-1021FEE39DFCQ49112834-6F98A398-8B95-4B3D-B1C8-6A26A1A7FA01Q50242144-46A6D963-EC7B-465C-A68A-0F20C6FF1630Q58716287-581EE4F9-4422-4951-A097-488F9484358D
P2860
Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Behavior and serotonergic diso ...... valproate: a model for autism.
@en
Behavior and serotonergic diso ...... valproate: a model for autism.
@nl
type
label
Behavior and serotonergic diso ...... valproate: a model for autism.
@en
Behavior and serotonergic diso ...... valproate: a model for autism.
@nl
prefLabel
Behavior and serotonergic diso ...... valproate: a model for autism.
@en
Behavior and serotonergic diso ...... valproate: a model for autism.
@nl
P2093
P50
P1433
P1476
Behavior and serotonergic diso ...... valproate: a model for autism.
@en
P2093
Anne-Marie Le Guisquet
David Ternant
Diane Dufour-Rainfray
Emilie Jaumain
Lucette Garreau
Patrick Vourc'h
Sylvie Bodard
Zuhal Gulhan
P356
10.1016/J.NEULET.2009.12.054
P407
P577
2009-12-28T00:00:00Z